Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04705480 · ClinicalTrials.gov registry record · Phase 4
Pregabalin vs. Gabapentin on Reducing Opioid Usage
A Phase 4 study, sponsored by CAMC Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 109
- Enrollment target
NCT04705480 is a Phase 4 study that has completed, run by CAMC Health System. The registered enrollment target is 109 participants.
The verdict
NCT04705480, a Phase 4 study, has completed, sponsored by CAMC Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 109 participants
- Enrollment target
Study Summary
This is a single-center, randomized, open-label, Phase 4 clinical trial investigating the efficacy of multiple-dose administrations of Pregabalin or Gabapentin in combination with traditional opioid pain medications to decrease the amount of opioid pain medication usage in single-system orthopedic trauma patients.
Interventions
- DRUG Pregabalin 50mg
- DRUG Gabapentin 300mg
- DRUG Neither Pregabalin nor Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2021-04-12 |
| Est. Completion | 2024-12-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04705480
The ClinicalTrials.gov registry entry for NCT04705480 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CAMC Health System, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Pregabalin 50mg is the first listed.
NCT04705480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04705480 about?
NCT04705480 is a clinical study titled "Pregabalin vs. Gabapentin on Reducing Opioid Usage". This is a single-center, randomized, open-label, Phase 4 clinical trial investigating the efficacy of multiple-dose administrations of Pregabalin or Gabapentin in combination with traditional opioid pain medications to decrease the amount of opioid pain medication usage in single-system orthopedic t...
What is the current status of trial NCT04705480?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 109 participants. The study started on 2021-04-12. Estimated completion is 2024-12-13.
What interventions are being tested in trial NCT04705480?
The interventions under investigation include: Pregabalin 50mg (DRUG), Gabapentin 300mg (DRUG), Neither Pregabalin nor Gabapentin (DRUG).
Who is sponsoring clinical trial NCT04705480?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.